The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Medi-Stim sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Medi-Stim is a medical equipment company that distributes electrotherapy devices and accessories. The company’s product portfolio includes Transcutaneous Electrical Nerve Stimulation (TENS) for pain control, Neuromuscular Electrical Stimulation (NMES or EMS) for muscle re-education, Microcurrent Electrical Nerve Stimulation (MENS), Interferential Stimulation (IF) for pain relief, High-Volt Pulsed Galvanic Stimulation (HVPG), Electromyography (EMG) and Iontophoresis for medication delivery. It also offers conductive garments, skin care products, batteries and other accessories. Medi-Stim is headquartered in Wabasha, Minnesota, the US.
The key metrics of Medi-Stim related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Medi-Stim is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Medi-Stim.
For a detailed understanding of the performance of Medi-Stim, buy the report here.